Cargando…
2022 Korean Liver Cancer Association-National Cancer Center Korea Practice Guidelines for Transarterial Therapy of Hepatocellular Carcinoma: What’s New?
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Radiology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830139/ https://www.ncbi.nlm.nih.gov/pubmed/36606613 http://dx.doi.org/10.3348/kjr.2022.0510 |
_version_ | 1784867606829727744 |
---|---|
author | Lee, In Joon Chun, Ho Jong Chung, Jin Wook |
author_facet | Lee, In Joon Chun, Ho Jong Chung, Jin Wook |
author_sort | Lee, In Joon |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9830139 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | The Korean Society of Radiology |
record_format | MEDLINE/PubMed |
spelling | pubmed-98301392023-01-19 2022 Korean Liver Cancer Association-National Cancer Center Korea Practice Guidelines for Transarterial Therapy of Hepatocellular Carcinoma: What’s New? Lee, In Joon Chun, Ho Jong Chung, Jin Wook Korean J Radiol Editorial The Korean Society of Radiology 2023-01 2023-01-02 /pmc/articles/PMC9830139/ /pubmed/36606613 http://dx.doi.org/10.3348/kjr.2022.0510 Text en Copyright © 2023 The Korean Society of Radiology https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0 (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Editorial Lee, In Joon Chun, Ho Jong Chung, Jin Wook 2022 Korean Liver Cancer Association-National Cancer Center Korea Practice Guidelines for Transarterial Therapy of Hepatocellular Carcinoma: What’s New? |
title | 2022 Korean Liver Cancer Association-National Cancer Center Korea Practice Guidelines for Transarterial Therapy of Hepatocellular Carcinoma: What’s New? |
title_full | 2022 Korean Liver Cancer Association-National Cancer Center Korea Practice Guidelines for Transarterial Therapy of Hepatocellular Carcinoma: What’s New? |
title_fullStr | 2022 Korean Liver Cancer Association-National Cancer Center Korea Practice Guidelines for Transarterial Therapy of Hepatocellular Carcinoma: What’s New? |
title_full_unstemmed | 2022 Korean Liver Cancer Association-National Cancer Center Korea Practice Guidelines for Transarterial Therapy of Hepatocellular Carcinoma: What’s New? |
title_short | 2022 Korean Liver Cancer Association-National Cancer Center Korea Practice Guidelines for Transarterial Therapy of Hepatocellular Carcinoma: What’s New? |
title_sort | 2022 korean liver cancer association-national cancer center korea practice guidelines for transarterial therapy of hepatocellular carcinoma: what’s new? |
topic | Editorial |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830139/ https://www.ncbi.nlm.nih.gov/pubmed/36606613 http://dx.doi.org/10.3348/kjr.2022.0510 |
work_keys_str_mv | AT leeinjoon 2022koreanlivercancerassociationnationalcancercenterkoreapracticeguidelinesfortransarterialtherapyofhepatocellularcarcinomawhatsnew AT chunhojong 2022koreanlivercancerassociationnationalcancercenterkoreapracticeguidelinesfortransarterialtherapyofhepatocellularcarcinomawhatsnew AT chungjinwook 2022koreanlivercancerassociationnationalcancercenterkoreapracticeguidelinesfortransarterialtherapyofhepatocellularcarcinomawhatsnew |